Swisspartners Ltd. Bristol Myers Squibb CO Transaction History

Swisspartners Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $2.43 Million - $2.68 Million	-33,500 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $482,670 - $562,680	9,000 Added 36.73%	33,500 $2.12 Million
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $355,020 - $415,860	-6,000 Reduced 19.67%	24,500 $1.45 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $1.45 Million - $1.64 Million	24,500 Added 408.33%	30,500 $1.93 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $346,440 - $392,580	6,000 New	6,000 $372,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Swisspartners Ltd., based on Form 13F filings with the SEC.

Stay updated on Swisspartners Ltd. with notifications on news.